198 related articles for article (PubMed ID: 1983195)
21. HLA-DP and susceptibility to insulin-dependent diabetes mellitus in an ethnically mixed population. Associations with other HLA-alleles.
Balducci-Silano PL; Layrisse ZE
J Autoimmun; 1995 Jun; 8(3):425-37. PubMed ID: 7576003
[TBL] [Abstract][Full Text] [Related]
22. [HLA-markers and diabetic retinopathy in the Senegalese population].
Cisse A; Chevenne D; Chauffert M; Ndiaye MR; Wade A; Trivin F
Dakar Med; 1998; 43(1):29-33. PubMed ID: 9827151
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneity of HLA genetic factors in IDDM susceptibility.
Martell M; Marcadet A; Moine A; Boitard C; Deschamps I; Dausset J; Bach JF; Cohen D
Immunogenetics; 1990; 31(4):233-40. PubMed ID: 1970333
[TBL] [Abstract][Full Text] [Related]
24. Restriction fragment length polymorphism analysis of HLA haplotypes in families with type I diabetes mellitus.
Badenhoop K; Schwarz G; Bingley P; Lewis V; Drummond V; Gale EA; Bottazzo GF
Tissue Antigens; 1990 Jan; 35(1):32-9. PubMed ID: 1968292
[TBL] [Abstract][Full Text] [Related]
25. Studies of HLA, factor B (Bf), complement C2 and C4 haplotypes in type 1 diabetic and control families from northern Sweden.
Hägglöf B; Holmgren G; Holmlund G; Lindblom B; Olaisen B; Teisberg P
Hum Hered; 1986; 36(4):201-12. PubMed ID: 3639057
[TBL] [Abstract][Full Text] [Related]
26. DQ beta restriction fragment length polymorphism in insulin dependent diabetes mellitus.
Brandt R; Zühlke H; Rjasanowski I; Michaelis D
Biomed Biochim Acta; 1990; 49(12):1211-7. PubMed ID: 1982986
[TBL] [Abstract][Full Text] [Related]
27. The histocompatibility system in juvenile, insulin-dependent diabetic multiplex kindreds.
Barbosa J; King R; Noreen H; Yunis EJ
J Clin Invest; 1977 Nov; 60(5):989-98. PubMed ID: 908763
[TBL] [Abstract][Full Text] [Related]
28. HLA class II (DR, DQ) in Japanese patients with type 1 diabetes mellitus.
Tanaka M; Abe J; Ito J; Horikawa R; Miki Y; Nakayama M; Kohsaka T; Tanae A; Hibi I
Acta Paediatr Jpn; 1990 Dec; 32(6):645-50. PubMed ID: 1982037
[TBL] [Abstract][Full Text] [Related]
29. C4 Chido 3 and 6 distinguish two diabetogenic haplotypes: HLA-B49, SC01,DR4,DQw8 and B8,SC01,DR3,DQw2.
Segurado OG; Giles CM; Iglesias-Casarrubios P; Corell A; Martinez-Laso J; Vicario JL; Arnaiz-Villena A
Immunobiology; 1991 Sep; 183(1-2):12-22. PubMed ID: 1682241
[TBL] [Abstract][Full Text] [Related]
30. Extended major histocompatibility complex haplotypes in type I diabetes mellitus.
Raum D; Awdeh Z; Yunis EJ; Alper CA; Gabbay KH
J Clin Invest; 1984 Aug; 74(2):449-54. PubMed ID: 6746903
[TBL] [Abstract][Full Text] [Related]
31. Extended HLA haplotypes in families with insulin-dependent diabetes mellitus in northern Finland.
Ilonen J; Surcel HM; Partanen J; Koskimies S; Knip M; Käär ML
Tissue Antigens; 1988 Sep; 32(3):139-44. PubMed ID: 3217930
[TBL] [Abstract][Full Text] [Related]
32. The susceptibility to insulin-dependent diabetes mellitus is associated with C4 allotypes independently of the association with HLA-DQ alleles in HLA-DR3,4 heterozygotes.
Thomsen M; Mølvig J; Zerbib A; de Preval C; Abbal M; Dugoujon JM; Ohayon E; Svejgaard A; Cambon-Thomsen A; Nerup J
Immunogenetics; 1988; 28(5):320-7. PubMed ID: 3139557
[TBL] [Abstract][Full Text] [Related]
33. Definition of IDDM-associated HLA DQ and DX RFLPs by segregation analysis of multiplex sibships.
Carrier CM; Mollen N; Rothman WC; Rodriguez de Cordoba S; Rey-Campos J; Ginsberg-Fellner F; Carpenter C; Rubinstein P
Hum Immunol; 1989 Jan; 24(1):51-63. PubMed ID: 2563360
[TBL] [Abstract][Full Text] [Related]
34. The HLA-DR4-associated DQw8 allele is confined to HLA-DR3/DR4 heterozygous type I (insulin-dependent) diabetics.
Boehm BO; Schifferdecker E; Rosak C; Kuehnl P; Driesel AJ; Schöffling K
Tissue Antigens; 1990 Aug; 36(2):81-2. PubMed ID: 1980162
[TBL] [Abstract][Full Text] [Related]
35. Tumour necrosis factor-beta gene RFLP alleles in Finnish IDDM haplotypes. The Childhood Diabetes in Finland (DiMe) Study Group.
Ilonen J; Merivuori H; Reijonen H; Knip M; Akerblom HK; Pociot F; Nerup J
Scand J Immunol; 1992 Dec; 36(6):779-83. PubMed ID: 1361076
[TBL] [Abstract][Full Text] [Related]
36. HLA-DP variation as additional risk factor in IDDM.
Easteal S; Kohonen-Corish MR; Zimmet P; Serjeantson SW
Diabetes; 1990 Jul; 39(7):855-7. PubMed ID: 1972363
[TBL] [Abstract][Full Text] [Related]
37. HLA and autoimmunity in North Indian type I (insulin-dependent) diabetic multiplex families.
Bhatia E; Mehra NK; Malaviya AN; Ahuja MM
Horm Metab Res; 1986 May; 18(5):331-4. PubMed ID: 3721405
[TBL] [Abstract][Full Text] [Related]
38. Study of cis and trans interactions between extended HLA-haplotypes in insulin-dependent diabetes.
Deschamps I; Marcelli-Barge A; Lallemand N; Poirier JC; Bochu V; Prévost P; Busson A; Massét M; Lestradet H; Hors J
Tissue Antigens; 1988 May; 31(5):259-69. PubMed ID: 3400091
[TBL] [Abstract][Full Text] [Related]
39. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus.
Pociot F; Mølvig J; Wogensen L; Worsaae H; Dalbøge H; Baek L; Nerup J
Scand J Immunol; 1991 Jan; 33(1):37-49. PubMed ID: 1996407
[TBL] [Abstract][Full Text] [Related]
40. A new HLA-DR2 extended haplotype is involved in insulin-dependent diabetes mellitus susceptibility.
Carcassi C; Trucco G; Trucco M; Contu L
Hum Immunol; 1991 Jul; 31(3):159-64. PubMed ID: 1890017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
